News

Press Releases

Neurotech appoints John Pollack, M.D. as Chief Medical Officer

View PDF Version

Rich Small, Chief Executive Officer presents at Eyecelerator 2020 Virtual Conference

Rich Small, Chief Executive Officer presents at Ophthalmology Futures Retina Forum

Neurotech Pharmaceuticals, Inc. Granted Fast Track

Neurotech Pharmaceuticals, Inc. Granted Fast Track Designation from the U.S. FDA for the Treatment of Macular Telangiectasia type 2. View...